Introduction
============

Adult epithelial tissues depend on the presence of self-renewing stem cells for their long-term homeostasis. Signals from the immediate stem cell microenvironment, or niche, promote stem cell self-renewal, prevent differentiation, and control stem cell proliferation to produce the specialized daughter cells required for tissue homeostasis. Emerging data support the idea that niches are adapted for specific stem cell needs. Classical niches consist of differentiated cells that directly contact stem cells and direct their self-renewal and behavior ([@bib30]). In contrast, other niches appear to lack a stable cellular component. Instead, stem cells generate some or all components necessary for their self-renewal and maintenance ([@bib33]; [@bib36]). The *Drosophila* ovary houses both types of niche in a structure called a germarium. Germline stem cells (GSCs) adhere directly to postmitotic cells called terminal filament and cap cells (apical cells), which are located at the apical tip of the germarium ([Fig. 1 A](#fig1){ref-type="fig"}; [@bib46]). This adhesion-based mechanism promotes GSC retention in the niche and concomitantly maintains stem cell fate.

![***boi* controls FSC proliferation.** (A) Schematic of early oogenesis. GSCs (gray) and ESCs (light blue) contact a cellular niche composed of terminal filament and cap cells ("apical cells," green). FSCs (red) reside 3--5 cell diameters posterior to apical cells. These stem cells generate daughter cells that coordinate to produce follicles (egg chambers) composed of a 16-cell germline cyst (gray) surrounded by a single follicular epithelial layer (yellow). Egg chambers develop over 7 d to produce mature eggs. (B--D) Germaria in which germ cells (blue, anti-Vasa) and differentiating follicle cells (red, anti-Fas3) are labeled. Stalks between the germarium and the first budded egg chamber average 9 cells in wild type (WT; B) and 18 cells in *boi^e^* mutants (C). Cell numbers for WT (B), and *boi^e^* (C and D) are indicated (brackets). Stalks with excess follicle cells are observed at later stages (B, arrow). (D) *boi* mutants exhibit defects in cyst packaging (indicated by side-by-side cysts in a single plane (white arrow) or two cysts surrounded by a single epithelium (green arrow), and polarization defects (round cells, changes in Fas3 staining; arrowheads). (E) Mean cell number in the first stalk for each genotype is shown. \*, significant differences relative to WT (P \< 0.00000006). (F) Mean numbers of dividing FSCs (PH3^+^) per germarium are shown. \*, significant differences relative to WT (P \< 0.002). Error bars represent SEM.](JCB_201007142_RGB_Fig1){#fig1}

In contrast, follicle stem cells (FSCs) lack a permanent cellular niche, instead relying on transient cell--cell and cell--matrix adhesion to maintain their position ([@bib39]; [@bib31]; [@bib33]). FSCs themselves produce the essential local niche component, Laminin A, which activates integrins on the FSC surface, thus promoting FSC anchoring and proliferation ([@bib33]). In addition, secreted signals produced by apical cells ([@bib8],[@bib9]; [@bib40]; [@bib18]) stimulate proliferation through canonical receptors expressed on the FSC surface, which is located 3--5 cell diameters to the posterior ([Fig. 1 A](#fig1){ref-type="fig"}; [@bib27]).

In one well-characterized example, Hedgehog (Hh) is expressed and secreted by apical cells ([@bib8]), and FSCs express its receptor, Patched (Ptc), and effector proteins Smoothened (Smo) and Cubitus Interruptus (Ci; the fly homologue of Gli; [@bib8],[@bib9]; [@bib49], [@bib50]). Current genetic data support a model in which apical cell-derived Hh interacts with Ptc expressed by FSCs, relieving Ptc-mediated inhibition of Smo and activating Ci-mediated target gene expression. FSC proliferation rates are affected by mutation of *hh*, *ptc*, or *smo* ([@bib8]; [@bib50]), which indicates an important role for this pathway in FSC proliferation control.

The recent identification of additional Hh receptors ([@bib24]; [@bib32]; [@bib41]; [@bib48]; [@bib51]; [@bib45]; [@bib47]) suggests that regulation of the FSC Hh response may be more complex. Ihog and its close homologue Boi bind Hh with high affinity ([@bib48]; [@bib28]) and are good candidate proteins for Hh regulation in the germarium. Ihog and Boi function redundantly, acting as coreceptors for Ptc to promote cell-autonomous Hh responses ([@bib47]; [@bib52]). The murine homologues of Ihog/Boi, called Cdo and Boc, also have been shown to act in Hh receiving cells to enhance signaling ([@bib32]; [@bib41]; [@bib51]). Although these experiments strongly indicate positive functions for Ihog/Boi and Cdo/Boc in Hh signaling during development, these receptors can limit Hh diffusion and negatively affect expression of Hh pathway reporters in some tissues ([@bib41]; [@bib47]). The dual function of Ihog/Boi in Hh regulation and the need for precise Hh levels for normal oogenesis suggest that assessing the role of these novel Hh receptors in the ovary could further our understanding of stem cell regulation.

Results and discussion
======================

Flies bearing homozygous or trans-heterozygous mutations in two loss-of-function *boi* mutant alleles exhibited excess follicle cells that accumulated between developing egg chambers ([Figs. 1](#fig1){ref-type="fig"} and [S1](http://www.jcb.org/cgi/content/full/jcb.201007142/DC1)). Although stalks of follicle cells between egg chambers in wild-type flies contained nine follicle cells on average, *boi* mutant stalks had twice as many cells ([Fig. 1, B--E](#fig1){ref-type="fig"}). Additional defects associated with excessive follicle cell production, including improper egg chamber packaging, delayed differentiation, and follicle cell polarity defects were also observed ([Fig. 1 D](#fig1){ref-type="fig"}). *boi* mutant FSCs proliferated more frequently than wild-type FSCs ([Fig. 1 F](#fig1){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}), which suggests that the increased numbers of follicle cells result, at least in part, from increased FSC proliferation in *boi* mutants. The number of dividing prefollicle cells derived from *boi* mutant FSCs was also higher than wild type (Fig. S1), perhaps because of the inability of mutant cells to differentiate properly ([@bib8]; [@bib49]; [@bib1]). Although previous studies have shown that Boi and its close relative Ihog both function in wing imaginal disc and embryonic development ([@bib48]; [@bib52]; [@bib47]), Ihog does not appear to play a role in the control of FSC proliferation, as loss-of-function mutants exhibited wild-type FSC proliferation and follicle production ([Fig. 1, E and F](#fig1){ref-type="fig"}; and [Table I](#tbl1){ref-type="table"}). Moreover, the penetrance and severity of *boi* mutant defects were not affected by reducing *ihog* levels (*boi; ihog/+*; [Fig. 1, E and F](#fig1){ref-type="fig"}; Fig. S1; and [Table I](#tbl1){ref-type="table"}). These results suggest that *boi* plays a critical, nonredundant role in FSC proliferation control.

###### 

Quantification of FSC and follicle cell proliferation

  Genotype                         Scoring average (SEM)[a](#tblfn1){ref-type="table-fn"}   P-value versus *w^1118^*, *109-30*, or *babGal 4* wild-type control[b](#tblfn2){ref-type="table-fn"}   P-value versus *boi^e^*, *boi^e^/109-30*, or *boi^e^/babGal 4* mutant controls[b](#tblfn2){ref-type="table-fn"}                                                                                       
  -------------------------------- -------------------------------------------------------- ------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------- --------------- ------------------- ------------- ----------------- --------------- ------------
  *W^1118^*                        38.5 (1.2)                                               0.55 (0.1)                                                                                             0.03 (0.02)                                                                                                       NA              NA                  NA            NA                NA              NA
  *boi^e01708^*                    57.3 (2.7)                                               4.73 (0.5)                                                                                             0.19 (0.04)                                                                                                       P ≤ 0.0000002   P ≤ 0.00000000002   P ≤ 0.0009    NA                NA              NA
  *boi^d04917^*                    39.2 (2.5)                                               1.68 (0.4)                                                                                             0.21 (0.08)                                                                                                       P ≤ 0.77        P ≤ 0.0006          P ≤ 0.001     P ≤ 0.00002       P ≤ 0.00006     P ≤ 0.81
  *boi^d^/boi^e^*                  37.2 (2.5)                                               1.88 (0.4)                                                                                             0.25 (0.08)                                                                                                       P ≤ 0.62        P ≤ 0.00009         P ≤ 0.002     P ≤ 0.000004      P ≤ 0.0002      P ≤ 0.46
  *ihog^e02142^*                   41.9 (2.2)                                               0.88 (0.3)                                                                                             0.04 (0.02)                                                                                                       P ≤ 0.154       P ≤ 0.226           P ≤ 0.72      P ≤ 0.0002        P ≤ 0.0000006   P ≤ 0.007
  *boi^e^; ihog^e/+^*              50.9 (2.1)                                               2.70 (0.4)                                                                                             0.22 (0.04)                                                                                                       P ≤ 0.0000009   P ≤ 0.00000002      P ≤ 0.0001    P \< 0.096        P \< 0.005      P \< 0.61
  *yw; smo^RNAi^/Cyo*              40.0 (2.0)                                               0.96 (0.3)                                                                                             0.05 (0.03)                                                                                                       P ≤ 0.509       P ≤ 0.124           P ≤ 0.5       P ≤ 0.00002       P ≤ 0.0000008   P ≤ 0.02
  *boi^e^; smo^RNAi^/Cyo*          43.6 (3.3)                                               2.63 (0.5)                                                                                             0.21 (0.06)                                                                                                       P ≤ 0.09        P ≤ 0.000001        P ≤ 0.001     P ≤ 0.002         P ≤ 0.007       P \< 0.8
  *Hh^AC^/+*                       33.6 (1.6)                                               1.48 (0.4)                                                                                             0.05 (0.02)                                                                                                       P ≤ 0.02        P ≤ 0.005           P ≤ 0.5       P ≤ 0.00000002    P ≤ 0.00002     P ≤ 0.005
  *boi^e^; Hh^AC^/+*               31.8 (1.3)                                               1.50 (0.3)                                                                                             0.08 (0.02)                                                                                                       P ≤ 0.0006      P ≤ 0.001           P ≤ 0.104     P ≤ 0.000000002   P ≤ 0.00002     P ≤ 0.016
  *smo^3b^/+*                      35.3 (1.9)                                               1.40 (0.2)                                                                                             0.07 (0.03)                                                                                                       P ≤ 0.15        P ≤ 0.001           P ≤ 0.2       P ≤ 0.0000002     P ≤ 0.000005    P ≤ 0.02
  *boi^e^; smo^3b^/+*              39.8 (1.8)                                               1.56 (0.3)                                                                                             0.07 (0.03)                                                                                                       P ≤ 0.55        P ≤ 0.001           P ≤ 0.309     P ≤ 0.00001       P ≤ 0.00002     P ≤ 0.038
  *boi^d^/boi^e^; smo^3b^/+*       39.3 (1.7)                                               0.84 (0.2)                                                                                             0.04 (0.04)                                                                                                       P ≤ 0.706       P ≤ 0.144           P ≤ 0.729     P ≤ 0.000007      P ≤ 0.0000002   P ≤ 0.043
  *babGal4/+*                      45.4 (2.3)                                               1.12 (0.3)                                                                                             0.04 (0.02)                                                                                                       NA              NA                  NA            NA                NA              NA
  *boi^e^; babGal4/+*              50.8 (2.3)                                               3.56 (0.4)                                                                                             0.24 (0.05)                                                                                                       P \< 0.1        P \< 0.000007       P \< 0.0002   NA                NA              NA
  *hh^RNAi^/babGal4*               36.1 (1.7)                                               0.68 (0.2)                                                                                             0.05 (0.03)                                                                                                       P ≤ 0.003       P ≤ 0.18            P ≤ 0.76      P ≤ 0.000006      P ≤ 0.0000001   P ≤ 0.0008
  *boi^e^; hh^RNAi^/babGal4*       42.1 (2.0)                                               1.92 (0.3)                                                                                             0.09 (0.03)                                                                                                       P ≤ 0.298       P ≤ 0.045           P ≤ 0.152     P ≤ 0.006         P ≤ 0.002       P ≤ 0.02
  *boi^e^; UAS-Boi/babGal4*        47.7 (2.0)                                               1.36 (0.3)                                                                                             0.05 (0.03)                                                                                                       P ≤ 0.459       P ≤ 0.55            P ≤ 0.76      P ≤ 0.31          P ≤ 0.00009     P ≤ 0.0008
  *boi^e^; UAS-Boi-ΔFN1/babGal4*   36.7 (1.8)                                               1.04 (0.3)                                                                                             0.19 (0.04)                                                                                                       P ≤ 0.005       P ≤ 0.85            P ≤ 0.001     P ≤ 0.00001       P ≤ 0.00001     P ≤ 0.44
  *boi^e^; UAS-Boi-ΔFN2/babGal4*   38.3 (1.5)                                               0.80 (0.3)                                                                                             0.12 (0.05)                                                                                                       P ≤ 0.01        P ≤ 0.4             P ≤ 0.08      P ≤ 0.00003       P ≤ 0.000001    P ≤ 0.12
  *boi RNAi \#4/babGal4*           38.6 (1.5)                                               0.96 (0.2)                                                                                             0.11 (0.04)                                                                                                       P ≤ 0.02        P ≤ 0.631           P ≤ 0.152     P ≤ 0.00006       P ≤ 0.0000009   P ≤ 0.05
  *109-30/cyo*                     38.5 (2.5)                                               0.96 (0.3)                                                                                             0.04 (0.02)                                                                                                       NA              NA                  NA            NA                NA              NA
  *boi^e^; 109-30/Cyo*             43.7 (3.4)                                               2.56 (0.4)                                                                                             0.20 (0.04)                                                                                                       P ≤ 0.219       P ≤ 0.001           P ≤ 0.007     NA                NA              NA
  *boi^e^; smo^RNAi^/109-30*       44.3 (2.2)                                               2.24 (0.4)                                                                                             0.04 (0.02)                                                                                                       P ≤ 0.089       P ≤ 0.007           P ≤ 1.0       P ≤ 0.89          P ≤ 0.544       P ≤ 0.007
  *smo^RNAi^/109-30*               34.9 (1.4)                                               0.64 (0.2)                                                                                             0.05 (0.04)                                                                                                       P ≤ 0.203       P ≤ 0.349           P ≤ 0.83      P ≤ 0.019         P ≤ 0.00006     P ≤ 0.023
  *Ci^RNAi^/109-30*                35.4 (1.5)                                               1.08 (0.3)                                                                                             0.09 (0.03)                                                                                                       P ≤ 0.29        P ≤ 0.75            P ≤ 0.22      P ≤ 0.03          P ≤ 0.002       P \< 0.05
  *boi^e^; Ci^RNAi^/109-30*        36.8 (1.8)                                               1.76 (0.4)                                                                                             0.06 (0.02)                                                                                                       P ≤ 0.56        P ≤ 0.08            P ≤ 0.58      P ≤ 0.08          P ≤ 0.13        P \< 0.003
  *boi^RNAi^ \#4/109-30*           35.1 (1.7)                                               0.28 (0.1)                                                                                             0.01 (0.01)                                                                                                       P ≤ 0.26        P ≤ 0.023           P ≤ 0.34      P ≤ 0.03          P ≤ 0.0000007   P \< 0.002

Between 25 and 150 germaria from 7-d-old female flies were scored per genotype for each condition. Mean numbers are shown with SEM.

A two-sample Student's *t* test was used for all statistical analysis. Significant differences were achieved at P ≤ 0.05.

Statistical analysis for the number of dividing FSC per germarium compared to wild-type or boi^e^ mutant controls are shown in bold.

Boi is a known Hh receptor ([@bib48]; [@bib28]), which suggests that direct Hh binding might contribute to Boi's role in suppressing FSC proliferation. Recent work in developing wing imaginal discs suggests that Boi functions as a coreceptor for Ptc, both stabilizing Ptc localization to the cell surface and promoting Hh pathway activation through Hh binding ([@bib52]). If a similar mechanism regulates FSC proliferation, Boi should be coexpressed together with Ptc in FSCs and be required cell autonomously within FSCs. Although low levels of Ptc were observed in most cells of the germarium including FSCs ([Fig. 2 A](#fig2){ref-type="fig"}; [@bib9]), Boi localized predominantly to the surface of apical cells ([Fig. 2, B and C](#fig2){ref-type="fig"}). Moreover, reducing endogenous *boi* levels in apical cells by cell-specific *boi* RNAi expression (*boi^RNAi^/+*; *babGal4/+*) led to follicle cell accumulation and FSC proliferation defects similar to those seen in *boi* homozygous mutants ([Fig. 2, D--G](#fig2){ref-type="fig"}; [Fig. S2](http://www.jcb.org/cgi/content/full/jcb.201007142/DC1); and [Table I](#tbl1){ref-type="table"}). In contrast, expression of *boi* RNAi in FSCs and their progeny (*boi^RNAi^/109-30 Gal4*) had no effect on follicle cell production or FSC proliferation ([Fig. 2, F and G](#fig2){ref-type="fig"}; and [Table I](#tbl1){ref-type="table"}). These data suggest that Boi functions in apical cells to suppress FSC proliferation rather than cell autonomously within FSCs.

![**Boi functions in apical cells to regulate FSC proliferation.** (A) Ptc expression (green) in wild-type (WT) germarium. Apical cells (red, anti-Hh) and FSC location (arrowhead) are indicated. (B and C) Boi (green) localizes predominantly to apical cells (brackets) in WT (B) but not *boi^e^* mutant (C) germaria. FSCs are indicated (arrowheads). (D and E) *UAS-boi^RNAi^* expression in apical cells reduces Boi levels. Boi (left), GFP (center), and germ cells (right, anti-Vasa) are labeled. WT germaria (D) express Boi but lack GFP. *UAS-boi^RNAi^*/*UAS-GFP; babGal4/+* germaria (E) lose Boi and gain GFP in apical cells. (F) Mean cell number in the first stalk for each genotype is shown. Significant differences relative to control (*109-30/+* or *babGal4/+*) are indicated (\*, P \< 0.000002). (G) Mean numbers of dividing FSCs (PH3+) per germarium are shown. Significant differences relative to control (*109-30/+* or *babGal4/+*) are indicated (\*, P \< 0.007). Error bars represent SEM.](JCB_201007142_RGB_Fig2){#fig2}

In wild-type germaria, Hh accumulates on the surface of the apical cells where it is produced rather than in the FSC niche ([Fig. 3 A](#fig3){ref-type="fig"}; [@bib8]). Moreover, ectopic Hh expression strongly promotes FSC proliferation ([@bib8],[@bib9]) which suggests that Hh release from apical cells may be a limiting event for FSC proliferation control. If this is the case, then Boi binding to Hh in apical cells may control Hh levels available to FSCs. Consistent with this model, a dramatic redistribution of Hh from apical cells to the extracellular space of the local FSC niche occurred in the absence of *boi*, without changes in Hh transcriptional activation ([Fig. 3 B](#fig3){ref-type="fig"} and [Fig. S3](http://www.jcb.org/cgi/content/full/jcb.201007142/DC1)). Expression of wild-type Boi in apical cells rescued both Hh localization and the *boi* mutant FSC hyperproliferation phenotypes (*boi*; *UAS-boi/+*; *babGal4/+*; [Fig. 3, C, F, and G](#fig3){ref-type="fig"}; and [Table I](#tbl1){ref-type="table"}). In contrast, a mutant form of Boi lacking the Hh-binding domain ([@bib48]; [@bib28]) failed to rescue both Hh localization and the *boi* mutant proliferation defects ([Fig. 3, D, F, and G](#fig3){ref-type="fig"}; and [Table I](#tbl1){ref-type="table"}), which suggests that direct binding of Hh to Boi mediates its function. Apical cell expression of Ihog, which also binds Hh directly ([@bib48]; [@bib28]), rescued *boi* mutant defects (*boi*; *ihog^EP^/+*; *babGal4/+*; [Fig. 3, E--G](#fig3){ref-type="fig"}; and [Table I](#tbl1){ref-type="table"}); this further supports the model that retention of Hh on the apical cell surface is critical for FSC proliferation control.

![**Boi sequesters Hh on the surface of apical cells.** (A and B) Wild-type (WT; A) or *boi^e^* mutant (B) germaria showing Boi (green) and Hh (red) expression in apical cells (brackets). Redistributed Hh is indicated (B, arrows). (C) Rescue of Hh (red) and Boi (green) localization by wild-type *boi* expression in apical cells (bracket, *boi^e^; UAS-boi/+; babGal4/+*). Nuclei are labeled (Draq5, blue). (D) Boi^ΔFN1^ (green) lacks the Hh-binding domain and fails to rescue Hh (red) localization (brackets, *boi^e^; UAS-boi^ΔFN1^/+; babGal4/+*). Hh accumulates near FSCs (arrows) as in *boi* mutants. (E) Ihog expression (*boi^e^; ihog^EP^/+; babGal4/+*) rescues Hh localization (red). Germ cells are labeled (anti-Vasa, blue). (F) Mean cell number in the first stalk for each genotype is shown. \*, significant differences relative to control (*babGal4/+*, P \< 0.00002). \*\*, significant differences relative to *boi^e^; babGal4/+* (P \< 0.00002). (G) Mean numbers of dividing FSCs (PH3+) per germarium are shown. \*, significant differences relative to control (*babGal4/+*, P \< 0.001). \*\*, significant differences relative to *boi^e^; babGal4/+*, (P \< 0.02). Error bars represent SEM.](JCB_201007142_RGB_Fig3){#fig3}

To confirm that the FSC hyperproliferation observed in *boi* mutants is caused by increased Hh signaling, we reduced the levels of (a) Hh ligand produced by apical cells or (b) Hh effector proteins in FSCs in *boi* mutant germaria. Consistent with the model, the FSC hyperproliferation and follicle cell accumulation defects observed in *boi* mutants were restored to wild-type levels by reducing Hh levels either in all cells of the germarium (*boi*; *hh^AC^*/+) or just in apical cells (*boi*; *hh^RNAi^/babGal4*; [Fig. 4, A and B](#fig4){ref-type="fig"}; and [Table I](#tbl1){ref-type="table"}). Moreover, genetic (*boi*; *smo^3^/+*) or RNAi-mediated reduction (*boi*; *smo^RNAi^/109-30 Gal4* or *boi*; *109-30 Gal4/+*; *Ci^RNAi^/+*) of Smo or Ci levels in *boi* mutants also suppressed *boi* mutant phenotypes ([Fig. 4, C and D](#fig4){ref-type="fig"}; [Table I](#tbl1){ref-type="table"}). Finally, the levels of activated Ci in FSCs and their derivatives were higher in *boi* mutants than in wild-type germaria (Fig. S3). Collectively, these data support the model that Boi binds and sequesters Hh on apical cells, limiting the levels of ligand available for receipt by FSCs and thus controlling their proliferation.

![**Boi acts through the canonical Hh pathway.** (A and B) Reducing Hh expression in all cells (*hh^AC^/+*) or in apical cells (*hh^RNAi^/bab-Gal4*) suppresses *boi* mutant defects. (A) The mean cell number in the first stalk for each genotype is shown. \*, significant differences relative to control (wild-type \[WT\] or *bab-Gal4/+*, P \< 0.00000006). \*\*, significant differences relative to *boi^e^* or *boi^e^*; *babGal4/+* (P \< 0.000001). (B) Mean numbers of dividing FSCs (PH3^+^) per germarium are shown for genotypes indicated. \*, significant differences relative to control (WT or *bab-Gal4/+*, P \< 0.0002). \*\*, significant differences relative to *boi^e^* or *boi^e^*; *bab-Gal4*/+ (P \< 0.02). (C and D) Reducing Smo or Ci expression in all cells (*smo^3^/+*) or in FSCs and their progeny (*smo^RNAi^/109-30-Gal4*, *or Ci^RNAi^/109-30-Gal4*) suppresses *boi* mutant defects. (C) Mean cell number in the first stalk for each genotype is shown. \*, significant differences relative to control (WT or *109-30/+*, P \< 0.0000009). \*\*, significant differences relative to *boi^e^* or *boi^e^*;*109-30/+* (P \< 0.00001). (D) Mean numbers of dividing FSCs per germarium (PH3^+^) are shown. \*, significant differences relative to control (WT or *109-30/+*, P \< 0.007). \*\*, significant differences relative to *boi^e^* or *boi^e^*;*109-30/+* (P \< 0.04). (E) Wild-type germaria immunostained with antibodies against Smo (green), Vasa (germ cells, blue), and Hh (red). Brackets indicate apical cells. (F) Mean cell number in the first stalk for each genotype is shown. \*, significant differences relative to control (*babGal4/+* or *109-30/+*, P \< 0.004). \*\*, significant differences relative to *boi^e^; babGal4/+*, P \< 0.0000002). (G) Expression of Boi^ΔFN2^ (green) in *boi* mutant apical cells (*boi^e^; UAS-boi^ΔFN2^/+; babGal4/+*) rescues Hh localization (red). Error bars represent SEM.](JCB_201007142_RGB_Fig4){#fig4}

In most documented cases, Boi and its homologues increase the local Hh concentration in cells that also express the Hh effector proteins Ptc, Smo, and Ci/Gli, promoting Hh signaling cell autonomously ([@bib32]; [@bib41]; [@bib48]; [@bib51], [@bib52]). Hh binds to apical cells in a Boi-dependent manner ([Fig. 3](#fig3){ref-type="fig"}), but the expression patterns of the downstream effectors Smo and Ci have not been documented. Strikingly, we found that Smo and the full-length, activated form of Ci were expressed in most cells of the germarium including FSCs, but were excluded from Boi-expressing apical cells ([Figs. 4 E](#fig4){ref-type="fig"} and S3). This suggests that Boi suppresses Hh signaling in cells lacking expression of its downstream effectors. Consistent with this idea, *boi* mutant defects were rescued by a form of Boi that lacks the Ptc-binding domain (*boi^e^*; *UAS-boi^ΔFN2^* /+; *babGal4/+*; [Fig. 4, F and G](#fig4){ref-type="fig"}; [@bib48]; [@bib28]), demonstrating that Boi-mediated suppression of FSC proliferation is Ptc independent. Finally, ectopic expression of Boi in FSCs and their progeny (*boi^EP^/+;109-30 Gal4/+*), the Hh target cells in this system, led to the accumulation of 1.5-fold excess follicle cells between stalks ([Fig. 4 F](#fig4){ref-type="fig"}). Thus, Hh signaling was enhanced in cells coexpressing Boi and Smo/Ci, which is consistent with observations in other fly tissues ([@bib48]; [@bib47]; [@bib52]). Together, these observations support the idea that the role of Boi in Hh signaling depends on the presence or absence of Hh pathway effectors in Boi-expressing cells.

Here we demonstrate that the primary function of Boi in FSC proliferation control is to limit the access of Hh ligand to FSCs. Similar nonautonomous inhibition of Sonic Hedgehog (Shh) signaling has been observed upon overexpression of the Boi/Ihog homologues Cdo or Boc in the developing chick neural tube ([@bib41]), which suggests that Hh sequestration may be a conserved function for Boi family members. However, roles for Boi or its homologues in nonautonomous control of stem cell factors have not been demonstrated previously. The requirement for precise control of Hh levels for proliferation control in prostate and neural stem cells ([@bib21]; [@bib26]; [@bib16]) suggests the possibility that this mechanism may be conserved in those tissues.

Although classical niches are composed of differentiated cells that provide all information necessary to direct stem cell fate ([@bib46]), FSCs rely on factors, including Hh, produced in cells residing at a distance from their immediate niche ([@bib8]; [@bib49]; [@bib50]; [@bib40]; [@bib18]). The benefit of this architecture for egg production is unclear. In other tissues, complex mechanisms control Hh transcription, secretion, cleavage, time of exposure, and range of diffusion in order to concentrate Hh signal on the appropriate receiving cells ([@bib7]; [@bib42]). In some cases, such as during neural tube development in mammals, the fate of several neural cells is determined by their position along a Shh concentration gradient ([@bib14]). In other cases, long-range Hh diffusion is blocked by strong expression of Ptc in cells close to the signal source, promoting short-range, high-level Hh stimulation ([@bib5]).

For FSC regulation, Hh likely acts as a long-range signal that diffuses in a gradient from the apical cells where it is produced ([@bib8],[@bib9]; [@bib49], [@bib50]). Perhaps an unidentified component of the FSC niche helps concentrate the ligand at the FSC surface, promoting proliferation. Hh accumulation in the extracellular space near FSCs in *boi* mutants ([Fig. 3](#fig3){ref-type="fig"}) supports this idea. Moreover, the FSC-autonomous requirement for *ptc*, *smo*, and *Ci* is consistent with direct, long-range stimulation of proliferation by Hh ([@bib8],[@bib9]; [@bib49], [@bib50]).

Hh also may act as a short-range morphogen in the ovary. Ptc and Smo are expressed in most cells of the germarium, including GSCs and escort stem cells (ESCs) lying immediately adjacent to apical cells ([Fig. 4](#fig4){ref-type="fig"}; [@bib8],[@bib9]). *ptc-lacZ* and *Ci-lacZ* reporters are strongly activated in ESCs and their progeny ([@bib9]; [@bib43]). Moreover, Hh expression in apical cells apparently coordinates FSC and GSC cell division via an undefined mechanism ([@bib17]). Perhaps Boi binds Hh within apical cells to increase its local concentration for short-range action, in a manner similar to that observed for the Decapentaplegic (Dpp) receptor Dally in GSC proliferation control ([@bib11]; [@bib13]). In this case, Hh might activate downstream signaling in ESCs, initiating a signaling relay system that affects GSC and FSC proliferation indirectly. Further work is needed to determine whether long-range, short-range, or both signaling mechanisms regulate stem cell proliferation in the ovary.

The role of nonadjacent growth factor producing cells in limiting stem cell proliferation signals may be a general mechanism in epithelial tissues. In the murine hair follicle and intestine, where stem cells can be identified in situ, underlying mesenchymal cells produce factors that are critical for stem cell self-renewal and function ([@bib35]; [@bib37]; [@bib20]; [@bib23]; [@bib29]). Transcriptional analysis indicates that these same cells express receptors that can limit the release or range of the growth factor signals they produce ([@bib35]; [@bib20]; [@bib23]). Although current data support critical functions for the growth factors in stem cell maintenance ([@bib3]; [@bib2]; [@bib29]), the roles of their membrane-bound inhibitors is less clear. Based on our observations, we propose that inhibitory receptors sequester ligand on the surface of the cells that produce them to limit the levels of signal available to the stem cell niche. If this model is correct, then the cellular source of secreted stem cell regulators that reside outside of the classical stem cell niche may be identified by the presence of membrane-bound receptors with high levels of surface-localized ligand. Understanding how these cells regulate stem cell function will be critical for treating stem cell--based diseases and for future development of effective stem cell replacement therapies.

Materials and methods
=====================

Fly strains
-----------

*boi^d04197^* (*boi^d^*), *boi^e01708^* (*boi^e^*), and *ihog^e02142^* (*ihog^e^*) were generated by Exelixis and maintained by the Harvard stock center. *boi^d^* and *boi^e^* are loss-of-function alleles expressing 8% and 0.2% of wild-type, full-length *boi* transcript, respectively, in the ovary (Fig. S1). *ihog^e^* has been described previously ([@bib48]; [@bib52]). In the ovary, 10% of full-length wild-type *ihog* transcript is expressed in *ihog^e^* mutants (Fig. S1). *smo^3^* ([@bib6]) and *hh^AC^* ([@bib22]) are null alleles of *smo* and *hh*, respectively. RNAi directed against *boi* (*boi^GD14474^* \[*boi^RNAi^ \#1*\] or *boi^GD60^* \[*boi^RNAi^\#4*\]), *smo* (*P{UAS-smo^RNAi^}2 P{UAS-smo^RNAi^}*), *Ci* (*P{TRiP.JF01715}attP2*), or *hh* (*P{TRiP.JF01804}attP2*) was expressed either in apical cells using *babGal4* (*P{GawB}bab1{Pgal4-2}*) or in FSCs and their progeny using *109-30-Gal4* (*P{GawB}109-30*) (Fig. S2). Boi was expressed in FSCs and their progeny by generating female flies of the genotype *boi^EP^/109-30* (*P{EPgy2}boi^EY09847^*/+;*109-30-Gal4/+*). Ihog was expressed in apical cells by generating female flies of the genotype *ihog^EP^* (*P{EP}ihog^G13202^*)/+; *bab-Gal4/+.*

Transgenic fly lines
--------------------

*pUASt-boi* (*UAS-boi*) was generated by cloning the full-length *boi* transcript *boi-RB* from pOT2-SD07678 (GenBank/EMBL/DDBJ accession No. [AY061833](AY061833), *Drosophila* Genomics Resource Center) into *pUASt*. *pUASt-boi^ΔFN1^* was created by site-directed excision of bases corresponding to amino acids 456--598 of Boi. *pUASt-boi^ΔFN2^* was created by site-directed excision of bases corresponding to amino acids 604--701 of Boi. *pUASt-boi*, *pUASt-boi^ΔFN1^*, and *pUASt-boi^ΔFN2^* were created using the Gateway *Drosophila* cloning system (Carnegie Institution of Washington). Transgenic flies were generated by Best-Gene, Inc. *pUASt-boi*, *pUASt-boi^ΔFN1^*, and *pUASt-boi^ΔFN2^* map to the second chromosome.

Generation of anti-Boi antibodies
---------------------------------

Polyclonal anti-Boi antibodies were developed from the injection of a GST fusion protein of amino acids 936--1013 (D isoform) in the cytoplasmic domain of all Boi isoforms into Sprague Dawley rats. Epitope identification was aided by the bioinformatics tools *Antigenic* ([@bib19]), *Phobius* ([@bib15]), *Disopred* ([@bib44]), and *Swiss EMBL* ([@bib38]). The construct was generated by amplifying the *boi* fragment using genomic PCR (5′-CATGGATCCC­ATCAGAATGGC­CTTCACCAC-3′ and 5'-GATATCTCGA­GCAGGGATGGT­ATCCTGGTC-3′) and cloning it into pGEX4T-2.

Immunofluorescence
------------------

Fly ovaries were dissected and fixed as described previously ([@bib33]). Wild-type and mutant ovaries were compared directly by dissecting, fixing, and immunostaining with premixed primary and secondary antibodies at the same time. For anti-Boi immunostaining, ovaries were fixed in 2% formaldehyde on ice. For nuclear staining, fixed ovaries were incubated for 15 min with Draq5 (Cell Signaling Technology). After staining, ovaries were mounted in Vectashield medium (Vector Laboratories). Primary antibodies were 1:50 rat anti-Boi, 1:2,000 rabbit anti-Vasa ([@bib12]); 1:100 rabbit anti-Hh (Calvados; provided by P. Therond, Institute of Developmental Biology and Cancer, Université Nice, Sophia Antipolis, Parc Valrose, France; [@bib10]), 1:100 goat anti-Hh (Santa Cruz Biotechnology, Inc.), 1:25 mouse anti-Fas3 (Developmental Studies Hybridoma Bank \[DSHB\]; [@bib34]); 1:1,000 rabbit anti--phospho-histone H3 (Millipore); 1:100 mouse anti-Ptc (DSHB; [@bib4]); and 1:100 mouse anti-Smo (DSHB; [@bib25]). Secondary antibodies used were FITC, Cy3, and Cy5 conjugated to species-specific secondary antibodies (Jackson ImmunoResearch Laboratories, Inc.). Samples were mounted in Vectashield mounting medium. Images were collected at room temperature (∼22°C) using 40× (1.25 NA) or 63× (1.4 NA) oil immersion lenses (Leica) on an upright microscope (DM 5000; Leica) coupled to a confocal laser scanner (TCS SP5; Leica). LAS AF SP5 software (Leica) was used for data acquisition. Images representing individual channels of single confocal slices from the center of each germarium were exported as TIFF files, and images were converted to figures using Photoshop software (Adobe). For analysis of Boi expression in wild-type or mutant tissue, ideal settings were determined for immunostaining wild-type tissue, and the level of signal in *boi* mutants was compared. To ensure that residual Boi expression was not observed in mutant tissue, the images presented were taken at higher gain than the wild-type tissue, resulting in slightly higher background levels than observed in the wild type.

RNA isolation and quantitative RT-PCR
-------------------------------------

For RNA isolation, whole ovaries were dissected from female flies. Ovaries were lysed with a dounce homogenizer and RNA isolated with an RNeasy kit (QIAGEN). RNA concentrations were determined with a spectrophotometer (NanoDrop; Thermo Fisher Scientific). For each sample, two reverse-transcription reactions were performed with 100 and 20 ng of input RNA. 5′ nuclease assays using TaqMan chemistry were run on a sequence detection system (7900 HT; Applied Biosystems). Ct (cycle threshold) values were converted to quantities (in arbitrary units) using standard curve (five points, fivefold dilutions) established with a calibrator sample. Quantitative real-time RT-PCR results were normalized to RPll140 mRNA levels. For each sample, the two values of relative quantity (from two PCR assays) were averaged, and a representative sample from three independent biological assays is shown. Full-length Boi oligos: forward, 5′-TGGATTTGGATAGAGGATTTAGCTG-3′; and reverse, 5′-GCTGTCTTGCTGTCTCTTTCCA-3′. Full-length Ihog oligos: forward, 5′-AAAACCAGCACCACAGAGGAG-3′; and reverse, 5′-ACTCATATTGAATGTCTCGTTATGACTG-3′.

Protein isolation and Western blot
----------------------------------

For protein isolation, whole ovaries were dissected from female flies, and ovaries were lysed using a dounce homogenizer and RIPA buffer (50 mM Tris, pH 8.0, 0.1% SDS, 1% Triton X-100, 150 mM NaCl, 1% deoxycholic acid, 2 mM PMSF, and protease inhibitors \[Sigma-Aldrich\]). Proteins were run on an 8% SDS-PAGE gel, then transferred to an Immobilon-P (Millipore) membrane. Membranes were probed with anti-Boi antibodies and β-tubulin (EMD).

Statistics
----------

To determine the number of follicle cells in the first stalk, 25--150 germaria were scored for follicle cell number (not touching a germ cell). Follicle cell number was compared with controls (*w^1118^*, *109-30/Cyo*, or *babGal4/+*) or *boi^e^* mutants (*boi^e^/boi^e^*, *boi^e^/boi^e^;109-30/Cyo*, or *boi^e^/boi^e^; babGal4/+*). Statistical differences were determined using the Wilcoxon two-sample test, with significance achieved at P ≤ 0.05. To determine the number of dividing follicle cells and FSCs per germarium, 75--150 germaria were analyzed for the presence of a phospho-histone-H3 positive (PH3^+^) FSC. FSCs were identified by their location at the border of germarial regions 2A and 2B, low-level expression of Fas3 (Fas3^lo^), a marker for prefollicle cells, and the presence of a triangular nucleus, a feature that distinguishes FSCs from their daughter cells and neighboring escort cells ([@bib31]). The number of PH3^+^ dividing FSCs was compared with controls (*w^1118^*, *109-30/Cyo*, or *babGal4/+*) or *boi^e^* mutants (*boi^e^/boi^e^*, *boi^e^/boi^e^;109-30/Cyo*, or *boi^e^/boi^e^; babGal4/+*). To measure dividing prefollicle cells, the total number of prefollicle cells that express high levels of Fas3 was determined by counting nuclei stained with Draq5. The number of PH3^+^ prefollicle cells in the same germaria was counted and a ratio of PH3^+^/total was determined. Statistical differences were determined using the Student's *t* test for two samples, with significance achieved at P ≤ 0.05.

Online supplemental material
----------------------------

Fig. S1 shows that insertion of transposable elements in *boi* intron 2 significantly reduces expression of *boi* mRNA. Fig. S2 shows expression of UAS transgenes in apical cells or FSCs and their progeny. Fig. S3 shows normal Hh transcription and increased Ci activity in *boi* mutants. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201007142/DC1>.
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